Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;35(6):1538-1540.
doi: 10.1038/s41433-021-01411-6. Epub 2021 Jan 29.

Hydroxychloroquine screening in the UK-closing the gaps

Anne Gobbett  1
Affiliations
Editorial

Hydroxychloroquine screening in the UK-closing the gaps

Anne Gobbett. Eye (Lond). 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132:1453–60. doi: 10.1001/jamaophthalmol.2014.3459. - DOI - PubMed
    1. Shee JC. Lupus erythematosus treated with chloroquine. Lancet. 1953;265:201–2. doi: 10.1016/S0140-6736(53)90138-X. - DOI - PubMed
    1. Hobbs HE, Sorsby A, Freedman A. Retinopathy following chloroquine therapy. Lancet. 1958;2:478–80. - PubMed
    1. Morsman CDG, Livesey SJ, Richards IM, Jessop JD, Mills PV. Screening for hydroxychloroquine retinal toxicity: Is it necessary? Eye. 1990;4:572–6. doi: 10.1038/eye.1990.79. - DOI - PubMed
    1. Wolfe F, Marmor MF. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010;62:775–84. doi: 10.1002/acr.20133. - DOI - PubMed

MeSH terms